Provided by Tiger Trade Technology Pte. Ltd.

Lexaria Bioscience Corp

3.21
-0.3400-9.58%
Post-market: 3.10-0.1100-3.43%19:30 EDT
Volume:123.68K
Turnover:404.06K
Market Cap:5.30M
PE:-0.62
High:3.93
Open:3.54
Low:2.98
Close:3.55
52wk High:23.25
52wk Low:2.98
Shares:1.65M
Float Shares:1.61M
Volume Ratio:0.77
T/O Rate:7.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.1429
EPS(LYR):-9.9189
ROE:-162.77%
ROA:-81.30%
PB:1.12
PE(LYR):-0.32

Loading ...

Lexaria Bioscience Warrants Exercised at Reduced Price of USD 12.92 Per Share

Reuters
·
Sep 08

Lexaria Bioscience to Present at H.C. Wainwright Global Investment Conference

Reuters
·
Sep 04

Lexaria Says DehydraTECH 3.0 Retatrutide Tablet Boosts Absorption up to 4,552% in Dog Study

Reuters
·
Aug 24

Lexaria Regains NASDAQ Bid Price Compliance, Avoids Delisting Hearing

Reuters
·
Aug 18

Lexaria Bioscience enters MTA with PegBio

TIPRANKS
·
Aug 17

Lexaria Bioscience - Mta to Investigate Co’s Dehydratech Technology with Proprietary Pegbio Molecule Under Development for Glp-1 Industry

THOMSON REUTERS
·
Aug 13

Lexaria Bioscience Corp - Enters a Material Transfer Agreement with Pegbio

THOMSON REUTERS
·
Aug 13

Lexaria Signs Material Transfer Agreement with PegBio to Test DehydraTECH with GLP-1 Molecule

Reuters
·
Aug 13

Lexaria Risks NASDAQ Delisting After Missing $1 Minimum Bid Price Rule

Reuters
·
Aug 11

Lexaria Bioscience Corp trading halted, volatility trading pause

TIPRANKS
·
Aug 03

NASDAQ Trade Halt Continues Volatility Trading Pause at 09:59 Am

Reuters
·
Aug 03

NASDAQ Trade Halt Continues Halt News Pending at 03:28 Am

Reuters
·
Aug 02

Lexaria Bioscience Corp trading halted, news pending

TIPRANKS
·
Aug 01

Lexaria Bioscience Corp - Authorizes 1-for-15 Reverse Stock Split - SEC Filing

THOMSON REUTERS
·
Jul 31

Lexaria Bioscience announces effective date for reverse stock split

TIPRANKS
·
Jul 30

Lexaria Bioscience to Execute 1-for-15 Reverse Stock Split Aug. 3

Reuters
·
Jul 30

Lexaria Bioscience Q3 EPS $(0.08) Beats $(0.09) Estimate

Benzinga Earnings
·
Jul 14

Lexaria FY26 Nine-month Net Loss Narrows to US$ 5.04 Million; Revenue Drops to US$ 20,000

Reuters
·
Jul 14

Lexaria Bioscience Corp Expected to Post a Loss of 8 Cents a Share - Earnings Preview

Reuters
·
Jul 10

Lexaria Bioscience ‘s human study GLP-1-H26-7 has begun dosing

TIPRANKS
·
Jun 25